Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gata2
|
ENSMUSG00000015053.8 | GATA binding protein 2 |
Gata1
|
ENSMUSG00000031162.8 | GATA binding protein 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_7966155_7966575 | Gata1 | 1545 | 0.196208 | 0.73 | 3.0e-11 | Click! |
chrX_7966827_7967869 | Gata1 | 562 | 0.549725 | 0.68 | 2.8e-09 | Click! |
chrX_7965299_7965608 | Gata1 | 1287 | 0.237807 | 0.66 | 9.3e-09 | Click! |
chrX_7968242_7968552 | Gata1 | 487 | 0.611068 | 0.65 | 2.5e-08 | Click! |
chrX_7964296_7964600 | Gata1 | 282 | 0.791786 | 0.64 | 4.0e-08 | Click! |
chr6_88198649_88199998 | Gata2 | 989 | 0.428565 | 0.38 | 2.7e-03 | Click! |
chr6_88198156_88198307 | Gata2 | 103 | 0.949184 | 0.34 | 8.3e-03 | Click! |
chr6_88196136_88197817 | Gata2 | 1358 | 0.317651 | 0.29 | 2.6e-02 | Click! |
chr6_88193441_88195010 | Gata2 | 334 | 0.821478 | 0.29 | 2.7e-02 | Click! |
chr6_88198328_88198634 | Gata2 | 147 | 0.933571 | 0.26 | 4.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_31612888_31614126 | 13.75 |
Gm43154 |
predicted gene 43154 |
8218 |
0.19 |
chr7_81057643_81058977 | 9.94 |
Alpk3 |
alpha-kinase 3 |
710 |
0.41 |
chr6_99172721_99173535 | 9.84 |
Foxp1 |
forkhead box P1 |
10110 |
0.29 |
chr8_80497324_80498362 | 9.48 |
Gypa |
glycophorin A |
4062 |
0.27 |
chr16_18429039_18430122 | 9.08 |
Txnrd2 |
thioredoxin reductase 2 |
655 |
0.54 |
chr9_21029266_21030734 | 8.98 |
Icam4 |
intercellular adhesion molecule 4, Landsteiner-Wiener blood group |
546 |
0.46 |
chr16_44765772_44766414 | 8.86 |
Cd200r1 |
CD200 receptor 1 |
267 |
0.88 |
chr8_84701273_84703379 | 8.72 |
Lyl1 |
lymphoblastomic leukemia 1 |
545 |
0.59 |
chr11_102363631_102364272 | 8.65 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
247 |
0.85 |
chr17_69105006_69106089 | 8.54 |
Epb41l3 |
erythrocyte membrane protein band 4.1 like 3 |
21453 |
0.26 |
chr14_63231019_63231782 | 8.25 |
Gata4 |
GATA binding protein 4 |
13848 |
0.16 |
chr19_17354797_17355050 | 8.24 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
1744 |
0.41 |
chr11_11836398_11837549 | 7.94 |
Ddc |
dopa decarboxylase |
693 |
0.68 |
chr7_113295089_113296008 | 7.83 |
Gm45355 |
predicted gene 45355 |
211 |
0.93 |
chr15_44457385_44458529 | 7.74 |
Pkhd1l1 |
polycystic kidney and hepatic disease 1-like 1 |
404 |
0.83 |
chr15_41751298_41752572 | 7.63 |
Oxr1 |
oxidation resistance 1 |
234 |
0.95 |
chr11_117781898_117782456 | 7.56 |
Tmc6 |
transmembrane channel-like gene family 6 |
21 |
0.57 |
chr10_45048086_45048775 | 7.49 |
Prep |
prolyl endopeptidase |
18773 |
0.15 |
chr18_11051784_11053949 | 7.42 |
Gata6 |
GATA binding protein 6 |
178 |
0.66 |
chr8_68205432_68207408 | 7.34 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
363 |
0.91 |
chr3_100486792_100487398 | 7.29 |
Tent5c |
terminal nucleotidyltransferase 5C |
2099 |
0.23 |
chr15_97379421_97380753 | 7.27 |
Pced1b |
PC-esterase domain containing 1B |
18870 |
0.24 |
chr2_17460205_17460550 | 7.13 |
Nebl |
nebulette |
244 |
0.96 |
chr10_108595779_108596540 | 7.10 |
Syt1 |
synaptotagmin I |
40805 |
0.18 |
chr5_105409514_105410008 | 7.10 |
Gm32051 |
predicted gene, 32051 |
394 |
0.82 |
chr17_48431455_48432112 | 6.85 |
Apobec2 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 |
835 |
0.47 |
chr11_109587022_109588156 | 6.82 |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
23843 |
0.13 |
chr9_24769617_24771807 | 6.74 |
Tbx20 |
T-box 20 |
962 |
0.56 |
chr5_119804344_119805024 | 6.65 |
1700021F13Rik |
RIKEN cDNA 1700021F13 gene |
2983 |
0.24 |
chr8_80868770_80869328 | 6.64 |
Gm31105 |
predicted gene, 31105 |
10891 |
0.18 |
chr5_100570574_100571670 | 6.58 |
Plac8 |
placenta-specific 8 |
1070 |
0.43 |
chrX_150547515_150548479 | 6.57 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
538 |
0.44 |
chr7_120879515_120880256 | 6.56 |
Eef2k |
eukaryotic elongation factor-2 kinase |
3665 |
0.15 |
chr15_83169748_83171160 | 6.55 |
Cyb5r3 |
cytochrome b5 reductase 3 |
52 |
0.95 |
chr3_101551232_101552184 | 6.51 |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
25852 |
0.16 |
chr1_36272569_36273936 | 6.37 |
Neurl3 |
neuralized E3 ubiquitin protein ligase 3 |
183 |
0.93 |
chr2_160326169_160327486 | 6.34 |
Gm826 |
predicted gene 826 |
667 |
0.78 |
chr1_173333573_173334024 | 6.31 |
Ackr1 |
atypical chemokine receptor 1 (Duffy blood group) |
48 |
0.97 |
chr10_93143259_93144113 | 6.27 |
Cdk17 |
cyclin-dependent kinase 17 |
17189 |
0.17 |
chr17_48271857_48272276 | 6.24 |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
373 |
0.79 |
chr3_97076352_97076977 | 6.18 |
4930573H18Rik |
RIKEN cDNA 4930573H18 gene |
16121 |
0.15 |
chr17_33713032_33713387 | 6.18 |
Marchf2 |
membrane associated ring-CH-type finger 2 |
172 |
0.9 |
chr3_127893429_127894301 | 6.12 |
Fam241a |
family with sequence similarity 241, member A |
2423 |
0.2 |
chr8_39010738_39011315 | 6.07 |
Tusc3 |
tumor suppressor candidate 3 |
5116 |
0.27 |
chr4_134864478_134865098 | 6.04 |
Rhd |
Rh blood group, D antigen |
252 |
0.91 |
chr10_98624508_98624896 | 5.97 |
Gm5427 |
predicted gene 5427 |
75008 |
0.11 |
chr3_137968340_137969523 | 5.96 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
12599 |
0.12 |
chr7_99824758_99826479 | 5.91 |
Neu3 |
neuraminidase 3 |
2799 |
0.17 |
chr2_91949326_91950727 | 5.90 |
Dgkz |
diacylglycerol kinase zeta |
285 |
0.84 |
chr12_76709116_76709328 | 5.86 |
Sptb |
spectrin beta, erythrocytic |
801 |
0.65 |
chr4_100994515_100995079 | 5.81 |
Cachd1 |
cache domain containing 1 |
87 |
0.97 |
chr11_61075424_61076210 | 5.69 |
Kcnj12 |
potassium inwardly-rectifying channel, subfamily J, member 12 |
10013 |
0.17 |
chr2_91119045_91119896 | 5.62 |
Mybpc3 |
myosin binding protein C, cardiac |
1326 |
0.3 |
chr7_19290671_19291896 | 5.61 |
Rtn2 |
reticulon 2 (Z-band associated protein) |
214 |
0.83 |
chr19_29066961_29067664 | 5.59 |
Gm9895 |
predicted gene 9895 |
35 |
0.96 |
chr5_117135847_117136233 | 5.59 |
Taok3 |
TAO kinase 3 |
2399 |
0.22 |
chr10_93672331_93673286 | 5.53 |
Gm8580 |
predicted gene 8580 |
6962 |
0.14 |
chr9_101198368_101199080 | 5.51 |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
127 |
0.94 |
chr8_67948178_67948899 | 5.51 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
3341 |
0.28 |
chr19_55925899_55926423 | 5.50 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
27852 |
0.21 |
chr4_151012060_151012982 | 5.48 |
Per3 |
period circadian clock 3 |
3624 |
0.19 |
chr12_88984474_88985246 | 5.47 |
Nrxn3 |
neurexin III |
31461 |
0.23 |
chr17_35200817_35202291 | 5.46 |
Tnf |
tumor necrosis factor |
450 |
0.46 |
chr14_121365539_121365809 | 5.44 |
Stk24 |
serine/threonine kinase 24 |
5806 |
0.22 |
chr6_41701642_41702158 | 5.44 |
Kel |
Kell blood group |
2439 |
0.19 |
chr6_58642449_58642948 | 5.44 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
2116 |
0.36 |
chrX_7966155_7966575 | 5.44 |
Gata1 |
GATA binding protein 1 |
1545 |
0.2 |
chr2_158145151_158146425 | 5.41 |
Tgm2 |
transglutaminase 2, C polypeptide |
578 |
0.71 |
chr13_95670683_95671105 | 5.39 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
625 |
0.66 |
chr17_45592643_45594205 | 5.38 |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
210 |
0.86 |
chr6_113690658_113691420 | 5.38 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
294 |
0.72 |
chr15_62098940_62099612 | 5.38 |
Pvt1 |
Pvt1 oncogene |
247 |
0.95 |
chr10_40140777_40141166 | 5.37 |
Slc16a10 |
solute carrier family 16 (monocarboxylic acid transporters), member 10 |
1283 |
0.36 |
chr12_108503155_108504028 | 5.36 |
Eml1 |
echinoderm microtubule associated protein like 1 |
31220 |
0.14 |
chr12_111028723_111029009 | 5.36 |
Gm48631 |
predicted gene, 48631 |
10464 |
0.12 |
chr8_120537063_120538443 | 5.35 |
1700016A09Rik |
RIKEN cDNA 1700016A09 gene |
27 |
0.8 |
chr5_143509158_143510231 | 5.34 |
Rac1 |
Rac family small GTPase 1 |
7914 |
0.12 |
chr11_78072614_78073453 | 5.33 |
Mir144 |
microRNA 144 |
28 |
0.51 |
chr10_54038732_54039013 | 5.32 |
Gm47917 |
predicted gene, 47917 |
24939 |
0.18 |
chr4_148670937_148671621 | 5.31 |
Gm572 |
predicted gene 572 |
27962 |
0.12 |
chr1_133799053_133799204 | 5.30 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
1908 |
0.26 |
chr17_25089311_25089630 | 5.25 |
Ift140 |
intraflagellar transport 140 |
1201 |
0.31 |
chr11_22170917_22171472 | 5.21 |
Ehbp1 |
EH domain binding protein 1 |
216 |
0.96 |
chr3_142757733_142758219 | 5.20 |
Gtf2b |
general transcription factor IIB |
7069 |
0.12 |
chr18_12166697_12167645 | 5.17 |
Rmc1 |
regulator of MON1-CCZ1 |
1546 |
0.29 |
chr1_161766766_161767491 | 5.12 |
Gm5049 |
predicted gene 5049 |
21072 |
0.12 |
chr7_75612178_75613652 | 5.12 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
631 |
0.75 |
chr7_44479611_44481283 | 5.11 |
5430431A17Rik |
RIKEN cDNA 5430431A17 gene |
4070 |
0.08 |
chr13_45545813_45546242 | 5.11 |
Gmpr |
guanosine monophosphate reductase |
126 |
0.98 |
chr4_153316698_153317280 | 5.09 |
Gm13174 |
predicted gene 13174 |
98813 |
0.08 |
chr18_12258021_12258704 | 5.05 |
Ankrd29 |
ankyrin repeat domain 29 |
13335 |
0.15 |
chr10_8130265_8131012 | 5.04 |
Gm30906 |
predicted gene, 30906 |
45493 |
0.17 |
chr6_5392013_5392545 | 5.02 |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
1852 |
0.43 |
chr10_119192545_119192983 | 4.99 |
Cand1 |
cullin associated and neddylation disassociated 1 |
15445 |
0.17 |
chr9_103288293_103288444 | 4.96 |
1300017J02Rik |
RIKEN cDNA 1300017J02 gene |
71 |
0.97 |
chr6_56920828_56921008 | 4.96 |
Nt5c3 |
5'-nucleotidase, cytosolic III |
2806 |
0.17 |
chr14_70621516_70621961 | 4.93 |
Dmtn |
dematin actin binding protein |
3193 |
0.15 |
chr15_34983215_34983492 | 4.93 |
Stk3 |
serine/threonine kinase 3 |
16569 |
0.26 |
chr10_40737288_40738233 | 4.93 |
Mettl24 |
methyltransferase like 24 |
54478 |
0.13 |
chr5_117133717_117134877 | 4.92 |
Taok3 |
TAO kinase 3 |
656 |
0.62 |
chr2_52618988_52619651 | 4.91 |
Bloc1s2-ps |
biogenesis of lysosomal organelles complex-1, subunit 2, pseudogene |
435 |
0.86 |
chr2_69670826_69672050 | 4.89 |
Klhl41 |
kelch-like 41 |
1318 |
0.37 |
chr19_36795668_36795946 | 4.88 |
Gm50112 |
predicted gene, 50112 |
22841 |
0.18 |
chr9_66127710_66127965 | 4.88 |
Ciao2a |
cytosolic iron-sulfur assembly component 2A |
1226 |
0.32 |
chr13_24420040_24420441 | 4.83 |
Cmah |
cytidine monophospho-N-acetylneuraminic acid hydroxylase |
3016 |
0.19 |
chr18_61505631_61506132 | 4.83 |
Arhgef37 |
Rho guanine nucleotide exchange factor (GEF) 37 |
3398 |
0.17 |
chr6_8755917_8756075 | 4.83 |
Ica1 |
islet cell autoantigen 1 |
2403 |
0.42 |
chr2_174298225_174300890 | 4.82 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
1698 |
0.27 |
chr5_33529197_33530303 | 4.81 |
Gm43851 |
predicted gene 43851 |
92286 |
0.05 |
chr16_34262533_34263234 | 4.81 |
Kalrn |
kalirin, RhoGEF kinase |
27 |
0.99 |
chr8_105823481_105824055 | 4.78 |
Ranbp10 |
RAN binding protein 10 |
3437 |
0.11 |
chr7_36166793_36167655 | 4.77 |
Rpl17-ps9 |
ribosomal protein L17, pseudogene 9 |
48950 |
0.14 |
chr9_64806162_64806616 | 4.77 |
Dennd4a |
DENN/MADD domain containing 4A |
4951 |
0.23 |
chr9_44339477_44339803 | 4.74 |
Hmbs |
hydroxymethylbilane synthase |
76 |
0.9 |
chr3_41522196_41522994 | 4.68 |
2400006E01Rik |
RIKEN cDNA 2400006E01 gene |
622 |
0.65 |
chr1_13293917_13294072 | 4.68 |
Gm38223 |
predicted gene, 38223 |
3488 |
0.15 |
chr2_93353181_93353959 | 4.65 |
Tspan18 |
tetraspanin 18 |
19065 |
0.16 |
chr7_24399064_24399607 | 4.62 |
Smg9 |
smg-9 homolog, nonsense mediated mRNA decay factor (C. elegans) |
284 |
0.81 |
chr7_115840871_115841134 | 4.59 |
Sox6 |
SRY (sex determining region Y)-box 6 |
5103 |
0.32 |
chrX_7964296_7964600 | 4.58 |
Gata1 |
GATA binding protein 1 |
282 |
0.79 |
chr15_73176794_73178055 | 4.57 |
Ago2 |
argonaute RISC catalytic subunit 2 |
423 |
0.85 |
chr2_163356404_163356958 | 4.56 |
Tox2 |
TOX high mobility group box family member 2 |
36303 |
0.11 |
chr2_147083670_147085642 | 4.54 |
Nkx2-4 |
NK2 homeobox 4 |
789 |
0.65 |
chr13_94806505_94807110 | 4.53 |
Tbca |
tubulin cofactor A |
10927 |
0.19 |
chr8_105819680_105819920 | 4.53 |
Ranbp10 |
RAN binding protein 10 |
7405 |
0.09 |
chr7_100494865_100496416 | 4.53 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
439 |
0.68 |
chr1_75463986_75464315 | 4.52 |
Gm37264 |
predicted gene, 37264 |
6611 |
0.09 |
chr15_67150917_67151367 | 4.50 |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
22119 |
0.23 |
chr17_62748947_62749663 | 4.48 |
Efna5 |
ephrin A5 |
131839 |
0.06 |
chr13_43235236_43235916 | 4.44 |
Tbc1d7 |
TBC1 domain family, member 7 |
64075 |
0.1 |
chr9_50602554_50602705 | 4.41 |
Sdhd |
succinate dehydrogenase complex, subunit D, integral membrane protein |
1183 |
0.25 |
chrX_8271051_8272966 | 4.41 |
Slc38a5 |
solute carrier family 38, member 5 |
366 |
0.82 |
chr5_23922845_23923208 | 4.41 |
Fam126a |
family with sequence similarity 126, member A |
122 |
0.95 |
chr8_122546551_122549259 | 4.41 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr5_105523041_105523801 | 4.38 |
Lrrc8c |
leucine rich repeat containing 8 family, member C |
3948 |
0.23 |
chr10_77159700_77160701 | 4.37 |
Col18a1 |
collagen, type XVIII, alpha 1 |
6348 |
0.2 |
chr6_56921888_56922511 | 4.36 |
Nt5c3 |
5'-nucleotidase, cytosolic III |
1525 |
0.25 |
chr16_85132591_85133705 | 4.35 |
Gm49226 |
predicted gene, 49226 |
15681 |
0.18 |
chr11_5009788_5010213 | 4.35 |
Ap1b1 |
adaptor protein complex AP-1, beta 1 subunit |
470 |
0.73 |
chr1_174173964_174174767 | 4.35 |
Spta1 |
spectrin alpha, erythrocytic 1 |
1589 |
0.22 |
chr5_119836535_119836877 | 4.34 |
Tbx5 |
T-box 5 |
551 |
0.74 |
chr8_88409434_88410114 | 4.33 |
Gm45497 |
predicted gene 45497 |
18653 |
0.2 |
chr10_111582974_111583647 | 4.33 |
4933440J02Rik |
RIKEN cDNA 4933440J02 gene |
10963 |
0.16 |
chr2_148038283_148039083 | 4.33 |
9030622O22Rik |
RIKEN cDNA 9030622O22 gene |
413 |
0.82 |
chr7_24372002_24372258 | 4.32 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
1792 |
0.18 |
chr9_50752994_50754649 | 4.32 |
Cryab |
crystallin, alpha B |
574 |
0.54 |
chr2_103957804_103957955 | 4.32 |
Lmo2 |
LIM domain only 2 |
107 |
0.96 |
chr6_122393478_122393837 | 4.30 |
1700063H04Rik |
RIKEN cDNA 1700063H04 gene |
2278 |
0.21 |
chr15_9073302_9073784 | 4.30 |
Nadk2 |
NAD kinase 2, mitochondrial |
1734 |
0.41 |
chr19_24554945_24555153 | 4.27 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
740 |
0.57 |
chr5_83354729_83355431 | 4.26 |
Tecrl |
trans-2,3-enoyl-CoA reductase-like |
115 |
0.98 |
chr13_95671197_95671708 | 4.25 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
67 |
0.96 |
chr11_54026747_54027441 | 4.25 |
Slc22a4 |
solute carrier family 22 (organic cation transporter), member 4 |
858 |
0.54 |
chr18_62110847_62111166 | 4.25 |
Gm41750 |
predicted gene, 41750 |
31612 |
0.18 |
chr6_97929540_97930859 | 4.24 |
Mitf |
melanogenesis associated transcription factor |
400 |
0.89 |
chr10_62327314_62328305 | 4.24 |
Hk1 |
hexokinase 1 |
42 |
0.97 |
chr19_55126480_55127385 | 4.24 |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
271 |
0.92 |
chr2_17459201_17459498 | 4.23 |
Nebl |
nebulette |
1272 |
0.59 |
chr10_63458795_63458946 | 4.23 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
1360 |
0.42 |
chr11_32296600_32297646 | 4.21 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
495 |
0.66 |
chr10_30754962_30755605 | 4.20 |
Gm48335 |
predicted gene, 48335 |
11321 |
0.14 |
chr16_38363598_38364152 | 4.19 |
Popdc2 |
popeye domain containing 2 |
1630 |
0.26 |
chr13_52283527_52283880 | 4.19 |
Gm48199 |
predicted gene, 48199 |
103292 |
0.07 |
chr4_88515521_88516207 | 4.18 |
Ifnb1 |
interferon beta 1, fibroblast |
6910 |
0.13 |
chr17_46885791_46886567 | 4.17 |
Tbcc |
tubulin-specific chaperone C |
4505 |
0.17 |
chr3_50815699_50816148 | 4.17 |
Gm24503 |
predicted gene, 24503 |
22792 |
0.2 |
chr3_135843805_135844446 | 4.11 |
4933401H06Rik |
RIKEN cDNA 4933401H06 gene |
3856 |
0.17 |
chr1_58969882_58970334 | 4.10 |
Trak2 |
trafficking protein, kinesin binding 2 |
3321 |
0.18 |
chr4_148667225_148668050 | 4.09 |
Gm572 |
predicted gene 572 |
24320 |
0.12 |
chr17_36020346_36021134 | 4.09 |
H2-T24 |
histocompatibility 2, T region locus 24 |
180 |
0.83 |
chr14_75139045_75139365 | 4.09 |
Gm15628 |
predicted gene 15628 |
2293 |
0.23 |
chrX_85576113_85576674 | 4.09 |
Tab3 |
TGF-beta activated kinase 1/MAP3K7 binding protein 3 |
2243 |
0.33 |
chr19_25381686_25382798 | 4.08 |
Kank1 |
KN motif and ankyrin repeat domains 1 |
13061 |
0.21 |
chr6_28424707_28425215 | 4.08 |
Gcc1 |
golgi coiled coil 1 |
808 |
0.41 |
chr12_105019423_105020291 | 4.06 |
Gm47648 |
predicted gene, 47648 |
1502 |
0.24 |
chr10_21054842_21055897 | 4.05 |
Gm20149 |
predicted gene, 20149 |
6470 |
0.16 |
chr9_32699930_32700500 | 4.05 |
Ets1 |
E26 avian leukemia oncogene 1, 5' domain |
3831 |
0.22 |
chr6_94729909_94730132 | 4.04 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
29862 |
0.17 |
chr10_93454496_93455097 | 4.04 |
Lta4h |
leukotriene A4 hydrolase |
1345 |
0.38 |
chr11_32283784_32284776 | 4.04 |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
469 |
0.66 |
chr17_24848553_24849107 | 4.04 |
Fahd1 |
fumarylacetoacetate hydrolase domain containing 1 |
1534 |
0.18 |
chr14_20662749_20662946 | 4.04 |
Synpo2l |
synaptopodin 2-like |
1727 |
0.18 |
chr18_50028322_50029158 | 4.02 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
2278 |
0.32 |
chr9_84112547_84113689 | 4.02 |
Bckdhb |
branched chain ketoacid dehydrogenase E1, beta polypeptide |
5611 |
0.27 |
chr7_100465236_100467118 | 4.02 |
C2cd3 |
C2 calcium-dependent domain containing 3 |
770 |
0.37 |
chr3_115793485_115793950 | 4.00 |
Gm9889 |
predicted gene 9889 |
78567 |
0.07 |
chr17_86185508_86186123 | 3.99 |
AC154542.1 |
TEC |
10240 |
0.2 |
chr7_116197315_116198543 | 3.98 |
Plekha7 |
pleckstrin homology domain containing, family A member 7 |
632 |
0.75 |
chr3_144198213_144200687 | 3.98 |
Gm43445 |
predicted gene 43445 |
188 |
0.94 |
chr8_33926179_33926910 | 3.98 |
Rbpms |
RNA binding protein gene with multiple splicing |
2732 |
0.25 |
chr1_120267677_120268469 | 3.98 |
Steap3 |
STEAP family member 3 |
2350 |
0.36 |
chr2_129201084_129201673 | 3.97 |
Slc20a1 |
solute carrier family 20, member 1 |
2068 |
0.15 |
chr11_121282665_121283154 | 3.97 |
Foxk2 |
forkhead box K2 |
7835 |
0.14 |
chr3_135827808_135828432 | 3.94 |
Slc39a8 |
solute carrier family 39 (metal ion transporter), member 8 |
2030 |
0.27 |
chr5_29467659_29468760 | 3.94 |
Mnx1 |
motor neuron and pancreas homeobox 1 |
10261 |
0.16 |
chr11_108248349_108248890 | 3.93 |
Gm11655 |
predicted gene 11655 |
66769 |
0.11 |
chr10_39612918_39613668 | 3.91 |
Traf3ip2 |
TRAF3 interacting protein 2 |
359 |
0.48 |
chr12_76673565_76674554 | 3.91 |
Sptb |
spectrin beta, erythrocytic |
35964 |
0.15 |
chr6_42352822_42353914 | 3.91 |
Zyx |
zyxin |
110 |
0.92 |
chr4_32868822_32869411 | 3.90 |
Ankrd6 |
ankyrin repeat domain 6 |
8433 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 13.7 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
2.5 | 7.4 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
2.4 | 7.3 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
2.1 | 4.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
2.1 | 6.3 | GO:0007525 | somatic muscle development(GO:0007525) |
2.0 | 6.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.0 | 6.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
2.0 | 7.9 | GO:0003175 | tricuspid valve development(GO:0003175) |
1.8 | 5.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.7 | 5.2 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.6 | 7.9 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.6 | 4.7 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.6 | 4.7 | GO:0002086 | diaphragm contraction(GO:0002086) |
1.5 | 9.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.4 | 2.9 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.4 | 4.2 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.4 | 4.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.4 | 4.1 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.3 | 4.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.3 | 4.0 | GO:0002432 | granuloma formation(GO:0002432) |
1.3 | 11.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.3 | 2.5 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.3 | 3.8 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.3 | 5.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.2 | 1.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.2 | 3.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.1 | 3.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.1 | 7.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.1 | 4.5 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
1.1 | 5.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.1 | 3.3 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.1 | 6.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.1 | 3.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.1 | 3.2 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
1.0 | 4.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.0 | 3.0 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
1.0 | 5.9 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
1.0 | 3.9 | GO:0070836 | caveola assembly(GO:0070836) |
0.9 | 2.8 | GO:1903416 | response to glycoside(GO:1903416) |
0.9 | 3.7 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.9 | 2.7 | GO:0042117 | monocyte activation(GO:0042117) |
0.9 | 3.6 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.9 | 5.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.9 | 3.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.9 | 4.3 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.8 | 5.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.8 | 1.7 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.8 | 4.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.8 | 19.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.8 | 3.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.8 | 2.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.8 | 5.4 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.7 | 1.5 | GO:0032672 | interleukin-3 production(GO:0032632) regulation of interleukin-3 production(GO:0032672) |
0.7 | 5.9 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.7 | 1.5 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.7 | 2.9 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.7 | 4.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.7 | 3.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.7 | 2.1 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.7 | 2.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.7 | 2.7 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.7 | 2.0 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.7 | 5.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.7 | 2.6 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.7 | 2.0 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.6 | 1.9 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.6 | 1.3 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.6 | 1.9 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.6 | 1.9 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.6 | 2.5 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.6 | 1.9 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.6 | 3.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 1.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.6 | 1.8 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.6 | 1.8 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.6 | 1.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.6 | 1.2 | GO:0048382 | mesendoderm development(GO:0048382) |
0.6 | 4.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.6 | 1.8 | GO:0035483 | gastric emptying(GO:0035483) |
0.6 | 1.2 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.6 | 2.4 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.6 | 1.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.6 | 2.9 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.6 | 0.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.6 | 1.2 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.6 | 8.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.6 | 5.1 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.6 | 1.1 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.6 | 0.6 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.6 | 1.7 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.6 | 0.6 | GO:0046102 | inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.6 | 0.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 1.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 2.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.6 | 6.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.6 | 1.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 2.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.5 | 1.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.5 | 4.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.5 | 1.6 | GO:0061511 | centriole elongation(GO:0061511) |
0.5 | 2.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 1.6 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.5 | 9.6 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.5 | 4.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.5 | 5.8 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.5 | 1.6 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.5 | 1.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 2.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.5 | 0.5 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.5 | 3.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.5 | 5.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.5 | 2.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.5 | 1.0 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.5 | 5.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.5 | 0.5 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.5 | 2.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.5 | 4.6 | GO:0070269 | pyroptosis(GO:0070269) |
0.5 | 0.5 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.5 | 7.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.5 | 2.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.5 | 2.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.5 | 1.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.5 | 2.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.5 | 1.0 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 4.5 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.5 | 7.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.5 | 0.5 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.5 | 1.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 0.5 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.5 | 0.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.5 | 0.5 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.5 | 2.4 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.5 | 1.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.5 | 1.4 | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) |
0.5 | 6.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.5 | 1.4 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.5 | 1.4 | GO:0008050 | female courtship behavior(GO:0008050) |
0.5 | 0.9 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.5 | 1.8 | GO:0008228 | opsonization(GO:0008228) |
0.5 | 1.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.5 | 1.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.5 | 1.8 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.5 | 1.4 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.4 | 5.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.4 | 1.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.4 | 1.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.4 | 0.9 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.4 | 1.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.4 | 0.4 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.4 | 2.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 1.3 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.4 | 1.3 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.4 | 3.9 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.4 | 0.4 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.4 | 0.8 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.4 | 1.7 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.4 | 8.3 | GO:0048821 | erythrocyte development(GO:0048821) |
0.4 | 0.8 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.4 | 0.4 | GO:0003032 | detection of oxygen(GO:0003032) |
0.4 | 0.4 | GO:1902109 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.4 | 5.7 | GO:0015858 | nucleoside transport(GO:0015858) |
0.4 | 0.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.4 | 2.4 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.4 | 0.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 0.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 0.4 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.4 | 0.8 | GO:0048069 | eye pigmentation(GO:0048069) |
0.4 | 1.2 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.4 | 0.8 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.4 | 1.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 1.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.4 | 1.6 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.4 | 4.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 1.2 | GO:0097286 | iron ion import(GO:0097286) |
0.4 | 1.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 1.5 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.4 | 2.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.4 | 1.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.4 | 0.8 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.4 | 1.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.4 | 1.1 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
0.4 | 1.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.4 | 3.7 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.4 | 1.5 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.4 | 1.1 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.4 | 1.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 0.7 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.4 | 1.5 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.4 | 0.4 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.4 | 1.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 1.4 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.4 | 1.8 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.4 | 2.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 1.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.4 | 0.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.4 | 0.7 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 2.5 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 1.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 1.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.4 | 1.8 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.4 | 1.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.3 | 0.7 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 3.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 1.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.3 | 0.7 | GO:0032513 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.3 | 2.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 0.3 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.3 | 2.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 0.7 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.3 | 0.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 4.3 | GO:0016556 | mRNA modification(GO:0016556) |
0.3 | 4.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 4.0 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 1.0 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.3 | 0.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 0.7 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.3 | 0.3 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.3 | 2.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 1.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 1.0 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.3 | 0.6 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.3 | 1.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 1.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.3 | 0.6 | GO:0036394 | amylase secretion(GO:0036394) |
0.3 | 0.3 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.3 | 2.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.3 | 1.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 1.3 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.3 | 3.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.3 | 0.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 5.7 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.3 | 0.6 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.3 | 1.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 0.6 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 0.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.3 | 0.9 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.3 | 0.9 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.3 | 3.0 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.3 | 2.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.3 | 0.6 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.3 | 0.3 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.3 | 2.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.3 | 6.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 2.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.3 | 0.9 | GO:0061010 | gall bladder development(GO:0061010) |
0.3 | 0.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 0.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 1.4 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.3 | 0.6 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.3 | 2.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 1.7 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.3 | 0.6 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.3 | 0.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 0.6 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.3 | 1.1 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) positive regulation of interferon-alpha production(GO:0032727) |
0.3 | 1.7 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
0.3 | 0.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.3 | 0.6 | GO:0015677 | copper ion import(GO:0015677) |
0.3 | 0.8 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.3 | 0.8 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 1.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 0.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 2.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.3 | 0.3 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.3 | 0.6 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.3 | 1.4 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.3 | 0.6 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.3 | 2.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.3 | 0.5 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 0.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 3.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 2.2 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 1.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 0.5 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 1.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 0.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 0.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 0.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.3 | 2.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.3 | 0.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.3 | 1.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 1.0 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.3 | 0.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 2.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 2.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.3 | 1.3 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.3 | 0.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 0.3 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.3 | 1.0 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.5 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.3 | 2.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.3 | 0.5 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 0.8 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.3 | 0.3 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.2 | 0.7 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 1.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.5 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 5.0 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 0.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.2 | 0.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.7 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 1.5 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 0.5 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.2 | 0.2 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.2 | 2.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.2 | 0.2 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.2 | 0.5 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 2.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 5.3 | GO:0030239 | myofibril assembly(GO:0030239) |
0.2 | 0.2 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 5.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.7 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.5 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.5 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.2 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 1.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 0.7 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.2 | 1.9 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.2 | 1.4 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.2 | 0.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.2 | 0.5 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.2 | 0.9 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.2 | 0.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.2 | 0.7 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 0.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 1.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.2 | 1.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 1.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 12.8 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 0.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.5 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.2 | 0.7 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 0.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.5 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.2 | 1.5 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 0.7 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.4 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.2 | 0.7 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 1.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 6.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 0.9 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 3.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.2 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.2 | 1.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.2 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 1.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 0.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 1.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 0.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.2 | 2.3 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 0.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 0.6 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.2 | 0.6 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.2 | 0.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 0.2 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.2 | 3.7 | GO:0009409 | response to cold(GO:0009409) |
0.2 | 0.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 0.2 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.2 | 0.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.8 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.2 | 1.4 | GO:0002467 | germinal center formation(GO:0002467) |
0.2 | 1.4 | GO:0002021 | response to dietary excess(GO:0002021) |
0.2 | 1.6 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 0.4 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.2 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 3.1 | GO:0034340 | response to type I interferon(GO:0034340) |
0.2 | 0.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 0.6 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.6 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.2 | 0.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 1.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 0.6 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 0.4 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.2 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.8 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 3.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 1.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 0.4 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.2 | 0.6 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.6 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.2 | 0.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 1.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 1.0 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 1.5 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.6 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 2.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 0.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 1.5 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 0.4 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.2 | 0.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.4 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.2 | 0.9 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 1.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 1.7 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 5.0 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.2 | 0.6 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 0.6 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 0.5 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.4 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.2 | 0.4 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 3.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 1.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 1.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.5 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 1.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 2.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 0.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 0.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 0.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.2 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.2 | 0.7 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.2 | 0.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 0.5 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 0.2 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.2 | 2.1 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.2 | 0.9 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.2 | 1.7 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.2 | 1.7 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.2 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.2 | 0.7 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 0.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 0.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.8 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 5.7 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 0.7 | GO:0018214 | protein carboxylation(GO:0018214) |
0.2 | 0.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 7.7 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.2 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.3 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.2 | 0.3 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.2 | 0.8 | GO:0003321 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.2 | 0.7 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.2 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.5 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.2 | 1.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.2 | 1.8 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.2 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 0.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 0.2 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.2 | 0.5 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 1.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.2 | 1.7 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.5 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.3 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.2 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.2 | 1.9 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 0.6 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 0.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 1.1 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.2 | 1.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.3 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 0.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 0.5 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.6 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 1.7 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.2 | 1.5 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.2 | 1.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.2 | 0.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 1.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 0.3 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.2 | 1.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.2 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.6 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 7.2 | GO:0051304 | chromosome separation(GO:0051304) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.3 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.9 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.4 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.6 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.3 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 0.7 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.3 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 1.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.3 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.1 | 0.1 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.1 | 0.3 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 4.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.1 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.1 | 3.6 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.1 | 1.1 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.3 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 2.6 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.3 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.4 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 2.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.7 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 2.7 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.1 | 0.8 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 1.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.4 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 0.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 0.3 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.1 | 0.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.5 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.1 | 0.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.3 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.3 | GO:1902074 | response to salt(GO:1902074) cellular response to salt(GO:1902075) |
0.1 | 0.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.1 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.1 | 1.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.8 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.1 | 3.2 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.4 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.3 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 3.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.3 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) |
0.1 | 0.2 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.1 | 0.7 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 0.5 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.2 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.1 | 0.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 1.6 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.1 | 0.4 | GO:0071459 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 1.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.5 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.2 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 1.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.2 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.4 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.7 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.4 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.1 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 0.5 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.7 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.1 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.1 | 0.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.2 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.1 | 0.4 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
0.1 | 0.5 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 1.4 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.5 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.1 | 0.2 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.8 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 4.3 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.1 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.2 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.1 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.2 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.2 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 0.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 2.4 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.4 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.9 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.1 | 1.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.3 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.1 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 0.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.4 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.1 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.1 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.4 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.1 | 0.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.4 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.3 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.8 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 0.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.3 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.3 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 0.7 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.2 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.1 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.7 | GO:0046479 | ganglioside catabolic process(GO:0006689) glycosphingolipid catabolic process(GO:0046479) |
0.1 | 0.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.1 | 0.3 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.1 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.1 | 0.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.2 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 0.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.2 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.5 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 3.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.5 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.5 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.1 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.1 | 0.5 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 1.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 1.5 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.3 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.1 | 0.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.2 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.2 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.1 | 0.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 0.3 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.6 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.9 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.3 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.1 | 0.4 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 0.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.1 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.1 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.1 | 0.2 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 0.4 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.6 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.8 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 1.6 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.2 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.3 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.1 | 0.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.1 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 0.3 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 0.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 0.5 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.2 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.2 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.2 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.6 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 1.1 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.1 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.3 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.2 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.1 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.1 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.3 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.1 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.1 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.1 | 0.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.4 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 1.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.2 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.1 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 1.0 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 1.2 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.3 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.1 | 0.8 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.1 | 0.3 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.1 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.2 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.1 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.1 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.5 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.1 | 0.1 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.1 | 0.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 1.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.3 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.1 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 1.0 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.5 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 1.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.2 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 0.3 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.8 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.3 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 1.2 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.1 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.2 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.2 | GO:0051458 | corticotropin secretion(GO:0051458) |
0.1 | 0.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.2 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.1 | 0.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.4 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.1 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.1 | 0.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.1 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.8 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.2 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.1 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.1 | 0.2 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.2 | GO:0032303 | regulation of icosanoid secretion(GO:0032303) |
0.1 | 0.1 | GO:0033084 | immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation in thymus(GO:0033084) positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.1 | 0.3 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0042454 | ribonucleoside catabolic process(GO:0042454) |
0.1 | 0.5 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.2 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.1 | 0.2 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.1 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.1 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.1 | 0.6 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.2 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.1 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 2.8 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.2 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.3 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.5 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.2 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.1 | 0.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.2 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.1 | GO:0072683 | T cell extravasation(GO:0072683) |
0.1 | 0.4 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.2 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.1 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.3 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.1 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 0.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 2.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.6 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.3 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 0.4 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.1 | 0.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.0 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.0 | 0.0 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.0 | 0.2 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.0 | 0.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.7 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.0 | 1.9 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 1.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.0 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.2 | GO:0006183 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) |
0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.0 | 0.0 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.0 | 1.6 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.0 | 0.0 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.0 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.0 | 0.0 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.0 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.0 | 0.1 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.3 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.0 | 0.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.0 | 0.1 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.0 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.5 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.0 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.0 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.0 | 0.1 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.0 | 0.6 | GO:0019915 | lipid storage(GO:0019915) |
0.0 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 0.0 | GO:0033572 | transferrin transport(GO:0033572) |
0.0 | 0.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.0 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.0 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.0 | 0.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.0 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.0 | 0.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.0 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.0 | 0.0 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.0 | 0.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.0 | 0.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.2 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.0 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.0 | 0.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.0 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:1990266 | neutrophil migration(GO:1990266) |
0.0 | 0.7 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.0 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 0.1 | GO:0045141 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic telomere clustering(GO:0045141) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.1 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.0 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.0 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.2 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.0 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
0.0 | 3.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.0 | 0.1 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.0 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.0 | 0.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.1 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.0 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.0 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 0.0 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.0 | 0.3 | GO:0048599 | oocyte development(GO:0048599) |
0.0 | 0.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.1 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.0 | 4.1 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.3 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.0 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.1 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.5 | GO:0001910 | regulation of leukocyte mediated cytotoxicity(GO:0001910) |
0.0 | 0.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.2 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.0 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.0 | 0.0 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.0 | 0.1 | GO:0044849 | estrous cycle(GO:0044849) |
0.0 | 0.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.0 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.8 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.1 | GO:0055022 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.0 | 0.0 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 3.0 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.0 | GO:0045869 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 1.0 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.0 | 0.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.0 | 0.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.1 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.5 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.1 | GO:0032369 | negative regulation of lipid transport(GO:0032369) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.0 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.0 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.0 | 0.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.0 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.0 | 0.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.0 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.0 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.0 | 0.2 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.0 | 0.0 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.0 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.0 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.0 | 0.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.1 | GO:0060420 | regulation of heart growth(GO:0060420) |
0.0 | 0.0 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.0 | 0.1 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.0 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.2 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 0.2 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.0 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.0 | 0.1 | GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
0.0 | 0.0 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.0 | 0.0 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.0 | 0.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.1 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.0 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.0 | GO:0045714 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.0 | 0.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.0 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.0 | 0.0 | GO:0043094 | cellular metabolic compound salvage(GO:0043094) |
0.0 | 0.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.5 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.0 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 0.0 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.0 | 0.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.1 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.0 | 0.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.0 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.0 | 0.0 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.0 | 0.0 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.0 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.0 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.1 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.0 | 0.0 | GO:0034204 | lipid translocation(GO:0034204) |
0.0 | 0.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.0 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.1 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.0 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.0 | 0.0 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.0 | 0.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 8.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.4 | 8.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.3 | 10.6 | GO:0005861 | troponin complex(GO:0005861) |
1.1 | 5.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.8 | 4.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.8 | 4.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.8 | 2.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.7 | 2.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.7 | 2.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.7 | 2.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.7 | 4.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.7 | 1.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.7 | 2.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.6 | 3.9 | GO:0031983 | vesicle lumen(GO:0031983) |
0.6 | 1.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.6 | 1.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.6 | 4.7 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.6 | 2.9 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.6 | 4.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.6 | 2.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.5 | 2.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 3.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 5.8 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.5 | 4.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 5.1 | GO:0031430 | M band(GO:0031430) |
0.5 | 1.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 1.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.4 | 1.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.4 | 1.2 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 1.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.4 | 1.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.4 | 1.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.4 | 1.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 7.5 | GO:0031672 | A band(GO:0031672) |
0.4 | 2.9 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 1.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.4 | 1.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.4 | 3.5 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 3.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 5.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 3.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 2.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 1.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 7.9 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 2.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 1.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.3 | 0.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 1.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 1.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 1.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 8.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 9.7 | GO:0014704 | intercalated disc(GO:0014704) |
0.3 | 0.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.3 | 0.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.3 | 4.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 1.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 2.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 3.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 3.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 2.5 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 2.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 13.6 | GO:0030018 | Z disc(GO:0030018) |
0.3 | 0.3 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.2 | 1.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 0.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 3.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 0.9 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 1.4 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 0.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 2.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 0.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 2.8 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 2.4 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 1.1 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 1.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 3.8 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 15.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 4.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 1.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 8.6 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 1.2 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 2.5 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 1.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 1.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 0.9 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 1.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 0.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 0.8 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 2.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 0.5 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 1.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 1.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 1.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 14.4 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 0.3 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 1.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.7 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.6 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.3 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.6 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.3 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 10.7 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 0.6 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 0.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.4 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 0.9 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.4 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.8 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.8 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.4 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.8 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.0 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 3.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 4.9 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 9.2 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 1.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 1.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.6 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 1.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 28.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.3 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 5.0 | GO:0043292 | contractile fiber(GO:0043292) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 1.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 9.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.3 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.9 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.6 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 1.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 5.4 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 1.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 1.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.7 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 1.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.1 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 1.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.4 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 1.1 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.7 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 0.5 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 1.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.5 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 5.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 2.4 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 2.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.3 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.1 | 13.0 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 3.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 1.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 0.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 3.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 4.1 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.1 | 0.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 1.2 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.4 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 8.2 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.6 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.1 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 1.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 2.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.4 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 5.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.2 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.7 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.7 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.2 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 1.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 2.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.6 | GO:0030894 | replisome(GO:0030894) |
0.0 | 1.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.2 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.0 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.0 | 0.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0005767 | secondary lysosome(GO:0005767) |
0.0 | 0.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.3 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.0 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 10.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.2 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.2 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 4.4 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.1 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 1.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.2 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.0 | 0.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 6.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 9.5 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.2 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 2.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.6 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 1.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 1.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.0 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.8 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 1.1 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.2 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.2 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.0 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 3.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.1 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.0 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.0 | GO:0005914 | spot adherens junction(GO:0005914) |
0.0 | 11.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.1 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 8.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.9 | 5.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.9 | 7.6 | GO:0031014 | troponin T binding(GO:0031014) |
1.7 | 5.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.3 | 3.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.3 | 5.1 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.2 | 3.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.2 | 3.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.2 | 7.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.0 | 8.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.0 | 8.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.0 | 4.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.0 | 1.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.0 | 2.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.0 | 3.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.0 | 2.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.9 | 6.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.9 | 2.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.9 | 5.2 | GO:0016631 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.9 | 4.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.8 | 3.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.8 | 2.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.8 | 10.1 | GO:0016208 | AMP binding(GO:0016208) |
0.8 | 6.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.8 | 3.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.8 | 1.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.7 | 3.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.7 | 1.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.7 | 2.1 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.7 | 1.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.7 | 2.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.7 | 3.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.7 | 2.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.7 | 3.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.7 | 2.6 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.6 | 2.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 1.9 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.6 | 4.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.6 | 1.9 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.6 | 1.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 11.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.6 | 2.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.6 | 2.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 3.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 7.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.5 | 1.6 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.5 | 4.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 2.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.5 | 3.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.5 | 2.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.5 | 2.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.5 | 5.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.5 | 4.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.5 | 2.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.5 | 2.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.5 | 1.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.5 | 1.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.5 | 1.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.5 | 1.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.5 | 3.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.5 | 10.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 1.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.5 | 0.5 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.5 | 16.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.5 | 1.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 1.8 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 1.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.5 | 1.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.5 | 1.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.5 | 2.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.4 | 2.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.4 | 1.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 0.4 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.4 | 1.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 1.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 1.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 4.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 3.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 2.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 4.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.4 | 3.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 1.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.4 | 1.3 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 2.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 1.7 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 6.0 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.4 | 2.6 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 1.7 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 0.8 | GO:0030172 | troponin C binding(GO:0030172) |
0.4 | 2.0 | GO:0031432 | titin binding(GO:0031432) |
0.4 | 2.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.4 | 4.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.4 | 0.8 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.4 | 1.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.4 | 4.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 2.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.4 | 1.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 1.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.4 | 1.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 1.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.4 | 1.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 1.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.4 | 1.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 1.8 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 1.1 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.4 | 5.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 11.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 0.7 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 1.4 | GO:0052717 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.3 | 3.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 2.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 8.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.3 | 1.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 2.3 | GO:0034560 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.3 | 6.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 3.8 | GO:0043176 | amine binding(GO:0043176) |
0.3 | 2.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 0.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.3 | 0.9 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.3 | 0.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 0.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 0.9 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.3 | 1.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 1.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.3 | 1.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 2.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 1.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 2.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 1.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 3.5 | GO:0031404 | chloride ion binding(GO:0031404) |
0.3 | 0.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 4.8 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.3 | 0.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 0.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 2.3 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.3 | 0.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 1.4 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 0.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 0.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.3 | 2.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 0.8 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 5.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 1.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 1.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 0.8 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 1.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.3 | 2.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 0.5 | GO:0035877 | death effector domain binding(GO:0035877) |
0.3 | 2.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 0.3 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.3 | 0.8 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.3 | 8.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.3 | 5.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 0.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 0.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 2.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 1.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 2.2 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 0.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 1.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 0.2 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.2 | 1.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 2.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 1.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 4.9 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 3.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 1.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 1.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.7 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 1.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 0.4 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 0.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 0.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 1.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 1.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 3.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 2.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 0.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 1.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.8 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 1.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 2.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 1.6 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 2.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 1.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 0.4 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 8.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 0.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 3.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 1.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 1.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 0.6 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.6 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 0.9 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 2.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.6 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 0.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 2.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.2 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.2 | 0.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 3.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 3.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 1.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.9 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 2.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 0.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 0.4 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.2 | 1.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 1.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 0.5 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 0.2 | GO:0060229 | lipase activator activity(GO:0060229) lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.5 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 3.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 4.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 0.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 0.6 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 1.0 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.2 | 10.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.6 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.2 | 2.8 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 2.6 | GO:0052713 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.2 | 1.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.6 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.4 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.1 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 1.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.4 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 4.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 1.9 | GO:0043748 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.1 | 3.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 1.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 2.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 2.8 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 4.0 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.1 | 1.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 2.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 1.3 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 0.7 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 2.0 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 1.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 3.8 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 1.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.4 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 1.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 1.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 2.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 3.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 1.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.8 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 10.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 5.0 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.9 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.1 | 0.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 1.5 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.4 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 1.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 2.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 1.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 1.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.5 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 1.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.7 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.3 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.9 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.3 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.4 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.3 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 3.1 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 0.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.2 | GO:0051380 | epinephrine binding(GO:0051379) norepinephrine binding(GO:0051380) |
0.1 | 0.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 1.8 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 15.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.2 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.6 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.4 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.1 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.1 | 3.6 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 1.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 4.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 0.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.5 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 1.1 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.5 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 0.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 0.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.8 | GO:0044606 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.1 | 0.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.3 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.7 | GO:0030487 | inositol-4,5-bisphosphate 5-phosphatase activity(GO:0030487) |
0.1 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 6.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.7 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.8 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 4.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 2.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 1.8 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 2.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 1.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 3.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 1.2 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 1.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 2.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.2 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.5 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 3.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 1.5 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.5 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 14.5 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 2.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.1 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 0.3 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.1 | 0.6 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 4.5 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.2 | GO:0016454 | C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.4 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 1.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.0 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.0 | 0.0 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.0 | 0.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 0.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 2.1 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.5 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 1.3 | GO:0010296 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.0 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.0 | 0.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 3.5 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.1 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.7 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 2.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.1 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.9 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.7 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.1 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.4 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 2.0 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 0.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 1.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.9 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 3.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.0 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.0 | 0.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.6 | GO:0015296 | anion:cation symporter activity(GO:0015296) |
0.0 | 0.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.5 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.7 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 1.0 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.0 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.0 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 3.0 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.0 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.0 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.0 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 1.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.8 | 1.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.7 | 0.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.6 | 1.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.5 | 4.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.5 | 6.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 2.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.4 | 1.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 4.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 13.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 13.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 7.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 11.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 8.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 7.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 14.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 1.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 8.3 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 2.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 11.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 8.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 2.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 0.3 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.3 | 1.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 6.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 5.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 1.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 1.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 5.1 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 6.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 4.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 5.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 6.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 4.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 0.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 8.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 1.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 8.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 2.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 4.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 1.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 8.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 1.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 2.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 2.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 1.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 5.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.2 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 2.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.9 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 4.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 3.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 1.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.3 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 1.4 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
1.1 | 13.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.8 | 6.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.6 | 15.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 9.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.5 | 0.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 7.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.5 | 6.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 0.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.5 | 4.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 1.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.4 | 5.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 7.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.4 | 1.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 14.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 3.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 0.7 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.4 | 3.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 5.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 1.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 3.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.3 | 1.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 7.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 6.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 2.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 9.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 2.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 3.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 3.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 2.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 7.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 2.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.3 | 1.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 0.5 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 23.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 2.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 6.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 1.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 0.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 9.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 1.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 4.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 0.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 2.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 1.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 0.8 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 0.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 2.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 5.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 4.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 1.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 0.2 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.2 | 2.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 0.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 8.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 1.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 1.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 1.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 1.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 5.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 1.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 2.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 0.7 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 6.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 1.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 0.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 0.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 4.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 2.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 3.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 0.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 0.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 4.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 2.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 3.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 1.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 1.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 2.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 2.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 2.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.2 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 2.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 3.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 4.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 8.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 6.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 3.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 0.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 8.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 2.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 1.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 2.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 8.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.3 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 1.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 5.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 4.5 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 0.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 3.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 3.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 4.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 0.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.8 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 0.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 2.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.1 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.1 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.8 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 2.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 1.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.1 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.0 | 0.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.6 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.5 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.0 | 1.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 1.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.6 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 4.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.6 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 3.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.5 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.1 | REACTOME APOPTOSIS | Genes involved in Apoptosis |